Target Name: MIR4694
NCBI ID: G100616426
Review Report on MIR4694 Target / Biomarker Content of Review Report on MIR4694 Target / Biomarker
MIR4694
Other Name(s): hsa-miR-4694-3p | hsa-miR-4694-5p | MicroRNA 4694 | hsa-mir-4694 | microRNA 4694

MIR4694: A Potential Drug Target and Biomarker

MIR4694 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to investigate, and a number of studies have shown promise in using it as a therapeutic agent.

MIR4694 is a microRNA (miRNA), a small non-coding RNA molecule that plays a critical role in post-transcriptional gene regulation. It is expressed in a variety of tissues and cells and is involved in the regulation of cell proliferation, differentiation, and survival.

One of the key features of MIR4694 is its ability to interact with other proteins and molecules. This interaction has led to its potential as a drug target. By interacting with specific proteins, MIR4694 can regulate their activity and ultimately affect cellular processes that are crucial for the disease.

One of the most promising aspects of MIR4694 is its potential as a cancer therapeutic. Cancer is a leading cause of death worldwide, and there is a high demand for effective treatments. MIR4694 has been shown to be involved in the regulation of cell proliferation and survival, which are key factors in the development and progression of cancer.

Research has shown that MIR4694 can be downregulated in cancer cells, which could make it an attractive target for cancer therapies. By increasing the expression of MIR4694, it may be possible to inhibit the growth and survival of cancer cells. This has the potential to be a valuable tool in the fight against cancer.

Another potential application of MIR4694 is its potential as a biomarker. The expression of MIR4694 has been shown to be associated with various diseases, including cancer, cardiovascular disease, and neurodegenerative diseases. By using MIR4694 as a biomarker, researchers may be able to diagnose and monitor these diseases more accurately.

In addition to its potential as a drug target and biomarker, MIR4694 also has interesting structural features that make it an attractive target for study. Its unique shape and composition have led to a high degree of structural flexibility, which allows it to interact with a wide range of molecules.

The structure of MIR4694 also allows it to form a complex with other proteins. This complex has been shown to have unique properties and functions, and may be a potential target for therapeutic intervention.

Overall, MIR4694 is a promising target for drug development and research. Its unique structure and function, as well as its potential as a cancer therapeutic and biomarker, make it an attractive candidate for further study.

While more research is needed to fully understand the potential of MIR4694, it is clear that it has the potential to be a valuable tool in the fight against disease. With further studies and research, it may be possible to unlock the full potential of this promising molecule.

Protein Name: MicroRNA 4694

The "MIR4694 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4694 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4695 | MIR4697 | MIR4697 host gene (non-protein coding) | MIR4698 | MIR4699 | MIR4700 | MIR4701 | MIR4703 | MIR4704 | MIR4706 | MIR4707 | MIR4708 | MIR4709 | MIR4711 | MIR4712 | MIR4713 | MIR4713HG | MIR4714 | MIR4715 | MIR4716 | MIR4717 | MIR4718 | MIR4720 | MIR4721 | MIR4722 | MIR4723 | MIR4724 | MIR4725 | MIR4726 | MIR4727 | MIR4728 | MIR4729 | MIR4730 | MIR4731 | MIR4732 | MIR4733 | MIR4734 | MIR4735 | MIR4736 | MIR4737 | MIR4738 | MIR4739 | MIR4740 | MIR4741 | MIR4742 | MIR4745 | MIR4746 | MIR4747 | MIR4749 | MIR4750 | MIR4751 | MIR4752 | MIR4753 | MIR4754 | MIR4755 | MIR4756 | MIR4757 | MIR4758 | MIR4759 | MIR4760 | MIR4761 | MIR4762 | MIR4763 | MIR4764 | MIR4765 | MIR4766 | MIR4767 | MIR4768 | MIR4769 | MIR4770 | MIR4771-1 | MIR4771-2 | MIR4772 | MIR4773-1 | MIR4773-2 | MIR4774 | MIR4775 | MIR4776-1 | MIR4776-2 | MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785 | MIR4786 | MIR4787 | MIR4789 | MIR4790 | MIR4791 | MIR4793 | MIR4794 | MIR4795 | MIR4796 | MIR4797 | MIR4798 | MIR4799